Keyword: Congress

Pharma has suffered another defeat in the state-by-state war over drug prices.

PhRMA called new donut-hole drug discounts a "massive bailout" for payers, but the insurance lobby says pharma's arguments are "ridiculous."

Pharma suffered a blow in the Senate's budget deal, but how much will drugmakers really lose? Not a lot, on average, but some will take a bigger hit.

Sen. Sanders said it's time for Congress to force CEOs to testify on the opioid crisis as lawyers negotiate a potential settlement.

Alex Azar is just one of hundreds who have glided through the "revolving door" between pharma and the federal government, Kaiser Health News found.

With an impending drop in the corporate tax rate, Pfizer is providing a preview of what Big Pharma's priorities are likely to be.

In the absence of national drug pricing reform in the U.S., many states are taking the issue into their own hands.

After falling short in its initial attempts to block a drug pricing measure in California, pharma is taking its argument to federal court.

A new report found that spending on pharmaceuticals grew at a much slower rate last year than in recent history.

Arizona's Medicaid would like to manage drug coverage to reduce costs, something currently prohibited under the Medicaid Drug Rebate Program.